recent
advanc
sequenc
technolog
transform
field
viru
discoveri
virom
analysi
mostli
confin
tradit
sanger
sequenc
base
individu
viru
discoveri
entir
replac
high
throughput
sequenc
ht
base
viru
metagenom
use
character
natur
composit
entir
virom
better
har
potenti
ht
studi
virom
sampl
prepar
methodolog
use
differ
approach
exclud
amplif
nonvir
compon
overshadow
lowtit
virus
virussequ
enrich
approach
mostli
focu
sampl
prepar
method
like
enzymat
digest
nonvir
nucleic
acid
size
exclus
nonvir
constitu
column
filtrat
ultrafiltr
densiti
gradient
centrifug
howev
recent
new
approach
virussequ
enrich
call
viromecaptur
sequenc
focus
amplif
ht
librari
prepar
stage
develop
increas
abil
virom
character
new
approach
potenti
transform
field
viru
discoveri
virom
analysi
technic
complex
sequencedepend
warrant
improv
review
discuss
differ
method
applic
evolut
select
sequenc
base
virom
analysi
also
propos
refin
need
har
full
potenti
ht
virom
analysi
despit
simplest
biolog
entiti
virus
play
enorm
import
complex
role
human
anim
health
environment
ecolog
also
known
shape
evolut
host
greenbaum
ghedin
koonin
dolja
koonin
et
al
koonin
wolf
mager
stoy
viru
discoveri
previou
centuri
follow
tradit
approach
viru
isol
amplif
cell
cultur
anim
model
leland
ginocchio
palacio
oberst
viru
isol
classifi
base
morpholog
serolog
properti
gelderblom
muir
et
al
wide
use
cell
cultur
isol
virus
fail
identifi
virus
refractori
grow
vitro
like
hepat
c
viru
hcv
choo
et
al
moreov
tradit
approach
includ
serolog
assay
pcr
specif
focus
group
virus
inher
depend
approach
biolog
properti
sequenc
known
virus
result
limit
knowledg
viru
world
koonin
shi
et
al
use
sequenc
depend
ie
gener
pcr
assay
microarray
sequenc
independ
ie
singl
primer
amplif
sispa
random
prime
approach
nucleic
acid
amplif
combin
sanger
sequenc
ht
allow
rapid
identif
new
virus
bishoplilli
et
al
chang
et
al
day
et
al
grard
et
al
kapoor
et
al
ladner
et
al
linnen
et
al
matsui
et
al
mokili
et
al
muerhoff
et
al
nichol
et
al
qin
et
al
quan
et
al
simon
et
al
fig
sispa
method
primerbind
sequenc
adapt
ligat
end
restrict
enzym
digest
dna
fragment
allow
subsequ
amplif
use
singl
primer
random
pcr
use
slightli
differ
approach
primerbind
sequenc
anneal
templat
use
oligo
contain
mixtur
four
nucleotid
termin
posit
end
howev
comprehens
identif
virus
given
sampl
pose
uniqu
challeng
due
tini
complex
natur
viral
genom
addit
absenc
conserv
anchor
sequenc
similar
bacteri
eukaryot
ribosom
sequenc
prohibit
panamplif
sequenc
virus
kapoor
lipkin
viral
sequenc
reduc
nonvir
sequenc
remain
unbias
toward
natur
composit
viru
genom
term
metagenom
defin
studi
genet
materi
recov
environment
sampl
handelsman
et
al
cultureindepend
natur
approach
allow
discoveri
unpreced
microbi
divers
remain
underestim
culturedepend
approach
vastli
use
inform
gain
bacteri
metagenom
studi
ignit
interest
marin
virologist
adapt
approach
viral
metagenom
breitbart
et
al
soon
sever
group
use
approach
modifi
form
identifi
human
anim
virus
earli
use
metagenom
approach
human
anim
clinic
sampl
success
new
virus
identifi
vitro
cultur
supernat
respiratori
secret
stool
suspens
urin
bodi
fluid
alland
et
al
alland
et
al
jone
et
al
kapoor
et
al
victoria
et
al
metagenom
remain
wide
use
approach
new
viru
identif
virom
analysi
date
discuss
use
limit
viru
metagenom
recent
use
select
sequenc
base
virom
analysi
provid
perspect
refin
viru
metagenom
base
approach
simpl
dideoxi
sanger
sequenc
applic
viral
metagenom
option
avail
process
involv
plasmid
clone
fragment
amplifi
nucleic
acid
environment
clinic
sampl
follow
sequenc
individu
clone
technic
cost
constrain
allow
sequenc
hundr
clone
earli
studi
even
small
scale
sequenc
reveal
presenc
vast
divers
among
viral
commun
also
led
identif
sever
human
anim
virus
clinic
sampl
alland
et
al
alland
et
al
chang
et
al
choo
et
al
kapoor
et
al
kapoor
et
al
linnen
et
al
matsui
et
al
muerhoff
et
al
nichol
et
al
nishizawa
et
al
van
der
hoek
et
al
victoria
et
al
studi
highlight
import
adapt
effici
sequenc
technolog
viral
metagenom
section
briefli
describ
differ
sequenc
platform
advantag
disadvantag
viru
metagenom
base
viru
identif
virom
analysi
first
ht
technolog
use
metagenom
base
viru
discoveri
principl
later
purchas
roch
technolog
sequencingbysynthesi
chemistri
dna
molecul
amplifi
emuls
pcr
gener
multipl
clone
dna
use
singl
templat
pyrophosph
releas
base
incorpor
enzymat
convert
light
signal
detect
use
charg
coupl
devic
camera
droeg
hill
sequenc
wide
use
identifi
sever
new
virus
virom
profil
human
anim
sampl
day
et
al
includ
arbovirus
bishoplilli
et
al
orbivirus
arenavirus
palacio
et
al
lujo
viru
bries
et
al
astroviru
quan
et
al
gyrovirus
phan
et
al
porcin
bocavirus
picornavirus
boro
et
al
rhabdovirus
grard
et
al
coronavirus
honkavuori
et
al
gammapapillomaviru
phan
et
al
seadornaviru
reuter
et
al
virus
identifi
sampl
like
serum
respiratori
fecal
sampl
studi
use
technolog
identifi
virus
tissu
organ
samplescanin
adenoviru
van
der
heijden
et
al
bat
hepaciviru
pegiviru
quan
et
al
method
gener
allow
sequenc
million
individu
read
nucleotid
long
although
technolog
offer
higher
yield
sanger
sequenc
lower
cost
technolog
supplant
ng
technolog
due
high
cost
error
rate
homopolymer
region
low
throughput
life
technologiesthermo
fisher
scientif
releas
phmediat
semiconductor
sequenc
technolog
base
ion
person
genom
machin
pgm
sequenc
platform
follow
ion
proton
posit
viral
probe
select
method
use
hybrid
base
captur
select
enrich
viru
nucleic
acid
follow
amplif
sequenc
sequenc
data
analysi
requir
bioinformat
base
viru
discoveri
virom
analysi
experiment
valid
result
kumar
et
al
viru
research
ion
seri
platform
conceptu
similar
pyrosequenc
platform
templat
prepar
sequenc
step
adapterlig
dna
fragment
amplifi
emulsionpcr
surfac
bead
distribut
microwel
sequencingbysynthesi
reaction
occur
proton
releas
nucleotid
incorpor
detect
use
ion
sensor
measur
slight
shift
ph
merriman
et
al
reuter
et
al
rapid
sequenc
run
make
sequenc
particularli
use
target
detect
virus
clinic
sampl
like
hiv
archer
et
al
chang
et
al
gibson
et
al
hepat
b
viru
yan
et
al
hcv
gaspareto
et
al
marascio
et
al
rapid
genom
sequenc
sever
virus
includ
toscana
viru
nougaired
et
al
polyomaviru
porcin
reproduct
respiratori
syndrom
viru
kvisgaard
et
al
orthoreoviru
steyer
et
al
bluetongu
viru
lorusso
et
al
rotaviru
ndze
et
al
nyaga
et
al
influenza
viru
van
den
hoeck
et
al
etc
although
studi
use
technolog
studi
virom
skin
bzhalava
et
al
tick
tokarz
et
al
xia
et
al
gut
virom
piglet
karlsson
et
al
seal
kluge
et
al
platform
ideal
choic
virom
studi
human
clinic
sampl
due
lower
output
solexaillumina
introduc
high
throughput
platform
less
expens
cost
genom
analyz
ii
platform
follow
miseq
nextseq
hiseq
seri
principl
illumina
sequenc
involv
reversibletermin
sequenc
synthesi
sb
fluoresc
label
nucleotid
liu
et
al
introduct
platform
acceler
rate
viru
discoveri
human
anim
like
sever
fever
thrombocytopenia
viru
xu
et
al
bascongo
viru
grard
et
al
titi
monkey
adenoviru
canin
bocaviru
snake
arenavirus
stenglein
et
al
human
polyomaviru
sauvag
et
al
simian
adenoviru
c
theiler
diseas
associ
viru
chandriani
et
al
human
hepegiviru
jingmen
tick
viru
qin
et
al
guaico
culex
viru
ladner
et
al
protoparvoviru
phan
et
al
marmota
himalayana
hepatoviru
yu
et
al
etc
high
throughput
low
error
rate
mainli
substitut
main
reason
illumina
technolog
domin
viral
discoveri
field
past
sever
year
pacif
bioscienc
commerci
singlemolecul
realtim
smrt
sequenc
platform
known
rs
ii
follow
sequel
gener
long
read
averag
kb
without
clonal
amplif
bia
hairpin
adapt
ligat
end
templat
dna
molecul
gener
cap
templat
smrtbell
zeromod
waveguid
zmw
singl
molecul
dna
fluoresc
nucleotid
affix
singl
dna
polymeras
enzym
bottom
polymer
fluoresc
tag
nucleotid
cleav
diffus
observ
area
zmw
detect
detector
real
time
reuter
et
al
rhoad
au
singl
molecul
sequenc
extrem
well
suit
viru
metagenom
studi
long
read
otherwis
nearli
imposs
obtain
long
contig
biolog
divers
sampl
brinzevich
et
al
tombacz
et
al
archer
et
al
bergfor
et
al
schleiss
et
al
tombacz
et
al
wittmann
et
al
lower
throughput
higher
cost
per
base
sequenc
higher
error
rate
current
limit
scope
viral
metagenom
studi
low
titer
virus
oxford
nanopor
technolog
releas
nanopor
base
portabl
sequenc
minion
principl
technolog
measur
inform
characterist
chang
induc
biolog
molecul
dnarna
pass
nanopor
molecular
motor
protein
first
portabl
sequenc
capabl
rnadna
sequenc
longer
read
length
approxim
kb
fewer
hour
real
time
sequenc
analysi
nanopor
platform
use
viral
detect
human
clinic
sampl
grening
et
al
hoenen
et
al
genom
sequenc
karamitro
et
al
kilianski
et
al
although
platform
look
promis
epidemiolog
investig
outbreak
low
output
high
error
rate
around
mcginn
et
al
concern
viru
discoveri
current
high
throughput
sequenc
technolog
capabl
produc
million
sequenc
read
detect
virus
clinic
sampl
still
challeng
due
presenc
extrem
low
amount
viral
nucleic
acid
compar
high
background
host
bacteri
contamin
genet
materi
therefor
effici
sensit
metagenom
studi
virus
clinic
environment
sampl
requir
remov
nonvir
nucleic
acid
andor
enrich
virusderiv
nucleic
acid
capobianchi
et
al
conceicaoneto
et
al
hall
et
al
viru
enrich
method
broadli
classifi
sampl
prepar
method
sequenc
librari
prepar
method
fig
altern
also
call
preextract
fig
postextract
viru
enrich
method
fig
respect
choic
preextract
viru
enrich
method
larg
depend
natur
sampl
analyz
gener
viru
metagenom
sampl
contamin
host
bacteria
eukaryot
environment
nucleic
acid
virom
analysi
environment
sampl
sever
method
includ
ultrafiltr
iron
chlorid
precipit
densiti
gradient
centrifug
polyethylen
glycol
sucros
cushion
avail
preextract
viru
enrich
andrewspfannkoch
et
al
john
et
al
virom
analysi
clinic
sampl
low
abund
host
cell
like
cerebrospin
fluid
respiratori
sampl
serum
urin
stool
filtrat
nucleas
digest
densiti
centrifug
use
method
preextract
viru
enrich
batti
et
al
conceicaoneto
et
al
dali
et
al
hall
et
al
kohl
et
al
rosseel
et
al
virom
analysi
clinic
sampl
abund
host
cell
like
blood
tissu
preextract
base
enrich
appropri
viru
genom
present
noncapsid
transcrib
form
preextract
viru
enrich
method
base
physic
properti
virion
differ
live
form
viru
particl
virion
encapsid
form
viru
genom
even
first
recognit
viru
entiti
earli
centuri
recogn
liquid
poison
done
abil
pass
cahmberland
filter
retain
bacteria
lecoq
except
larg
recent
identifi
virus
anim
virus
less
nm
diamet
therefor
pass
filter
pore
size
filtrat
therefor
commonli
use
method
select
sequenc
virus
environment
clinic
sampl
notabl
sever
metagenom
base
viru
identif
studi
use
filter
filter
pore
diamet
commerci
filter
quit
variabl
use
filter
pore
diamet
closer
viru
size
reduc
amount
virus
filtrat
conceicaoneto
et
al
compact
natur
virion
allow
use
densiti
gradient
centrifug
sucros
cesium
chlorid
poli
ethylen
glycol
method
enrich
sampl
viru
deriv
nucleic
acid
densiti
centrifug
commonli
use
molecular
virolog
lab
also
use
first
viru
metagenom
studi
enrich
virus
sea
water
sampl
method
also
use
studi
virom
lake
soil
extrem
environ
brum
et
al
kleiner
et
al
thurber
et
al
major
limit
densiti
centrifug
method
applic
analysi
clinic
sampl
moreov
differ
densiti
envelop
nonenvelop
virus
variabl
requir
analysi
sever
gradient
fraction
presenc
contamin
nucleic
acid
densiti
gradient
solut
contamin
sampl
environment
nucleic
acid
viral
capsid
protect
genom
degrad
nucleas
properti
virion
frequent
use
plant
anim
virologist
identif
transmiss
virus
rosseel
et
al
thurber
et
al
howev
nucleas
treatment
nucleas
mediat
remov
noncapsid
nucleic
acid
enrich
sampl
viral
nucleic
acid
first
describ
alland
et
al
alland
et
al
studi
show
dnase
treatment
viru
contain
serum
sampl
help
enrich
metagenom
librari
viru
deriv
sequenc
work
describ
identif
two
novel
parvoviru
speci
bovin
serum
soon
group
sever
other
use
similar
approach
identifi
plethora
human
anim
virus
add
ref
although
help
nucleas
treatment
effect
degrad
unprotect
nucleic
acid
often
fail
enrich
sampl
enough
identif
lowtit
virus
moreov
nucleas
treatment
use
find
virus
cell
tissu
sampl
viru
nucleic
acid
encapsid
form
posit
select
method
sampl
enrich
viral
nucleic
acid
directli
use
probe
target
virus
like
pcr
assay
microarray
viru
captur
solut
base
hybrid
approach
simplest
exampl
posit
select
approach
gener
pcr
assay
use
degener
primer
target
sever
relat
virus
variant
irv
et
al
kwok
chiang
simon
et
al
pcr
base
approach
restrict
abil
detect
limit
number
virus
due
issu
multiplex
avoid
sever
group
develop
posit
select
approach
enrich
sampl
virus
defin
taxonom
group
famili
genu
speci
base
dna
microarray
gardner
et
al
palacio
et
al
wang
et
al
dna
microarray
employ
character
discov
number
novel
variant
virus
includ
human
cardiovirus
porcin
circoviru
rhinoviru
adenoviru
respect
chiu
et
al
kistler
et
al
palacio
et
al
rota
et
al
howev
due
limit
specif
none
method
suitabl
comprehens
character
vertebr
virus
analysi
virom
recent
two
comprehens
probe
set
develop
posit
select
base
sequenc
known
vertebr
virus
variant
bries
et
al
wyli
et
al
method
use
virusspecif
probe
liquidphas
hybrid
captur
viral
sequenc
metagenom
librari
one
approach
term
virom
captur
sequenc
vircapseq
bries
et
al
basic
vircapseq
similar
dna
hybrid
base
enrich
method
includ
wellknown
exon
captur
method
use
transcriptom
principl
vircapseq
made
set
specif
oligonucleotid
probe
like
use
viral
microarray
mix
sampl
hybrid
captur
complementari
viral
nucleic
acid
fig
vircapseq
includ
probe
virus
known
infect
vertebr
target
protein
code
region
howev
design
vircapseq
challeng
due
constant
influx
genom
data
newli
identifi
virus
bias
abund
viru
genom
pathogen
virus
like
hiv
hcv
sequenc
databas
design
vircapseq
therefor
requir
use
uniqu
probe
set
contain
million
probe
oligonucleotid
differ
least
reduc
sequenc
redund
widen
coverag
viru
sequenc
stringent
hybrid
condit
vircapseq
allow
specif
enrich
viruslik
sequenc
librari
gener
differ
sampl
type
compar
common
metagenom
viru
enrich
approach
filtrat
nucleas
digest
prior
total
nucleic
acid
extract
ribozero
rrna
deplet
extract
use
vircapseq
gain
viru
sequenc
metagenom
librari
sensit
vircapseq
also
compar
real
time
pcr
detect
viral
sequenc
blood
serum
sampl
spike
live
enteroviru
vircapseq
abl
detect
copiesml
viru
sampl
type
compar
sensit
pcr
base
method
interestingli
use
vircapseq
allow
identif
virus
whose
genom
vastli
differ
use
design
probe
virus
taxonom
group
share
highli
conserv
stretch
nucleotid
anoth
similar
posit
select
approach
term
virocap
simultan
develop
wyli
etal
wyli
et
al
like
vircapseq
virocap
also
target
viru
speci
viru
famili
known
infect
vertebr
exclud
known
endogen
retrovirus
design
virocap
approxim
billion
base
sequenc
data
condens
million
base
probe
sequenc
use
virocap
allow
increas
number
viru
read
compar
simpl
metagenom
sequenc
although
posit
select
approach
describ
bias
toward
sequenc
known
virus
effici
use
studi
mix
infect
provid
sensit
character
virus
present
clinic
sampl
appreci
role
virom
play
human
health
increas
platform
provid
use
tool
studi
dynam
human
virom
longitudin
sampl
collect
appear
diseas
ideal
neg
subtract
strategi
would
allow
remov
nonvir
nucleic
acid
sampl
includ
nucleic
acid
deriv
host
reagent
environ
neg
select
approach
use
principl
suppress
subtract
hybrid
ssh
represent
differ
analysi
rda
allow
comparison
two
dna
popul
tester
driver
enrich
differenti
distribut
molecul
diatchenko
et
al
lisitsyn
et
al
genom
dna
sampl
contain
sequenc
interest
refer
tester
refer
sampl
refer
driver
tester
driver
dna
hybrid
excess
driver
hybrid
sequenc
remov
consequ
remain
unhybrid
dna
repres
dna
molecul
present
tester
yet
absent
driver
dna
although
approach
usual
employ
identifi
gene
differenti
express
pattern
yin
et
al
success
use
identifi
human
herp
chang
et
al
gb
viru
simon
et
al
tt
viru
nishizawa
et
al
walru
caliciviru
ganovaraeva
et
al
new
strain
murin
hepat
viru
islam
et
al
anoth
simpler
approach
base
simpl
subtract
nontarget
nucleic
acid
use
biotinyl
probe
fig
exampl
neg
select
approach
subtract
ribosom
rna
rrna
extract
ribonucl
acid
method
effici
find
rna
virus
sampl
like
serum
cerebrospin
fluid
major
host
rna
rrna
matranga
et
al
rosseel
et
al
sever
commerci
kit
includ
illumina
ribozero
rrna
remov
kit
ambion
globinclear
kit
provid
sequenc
specif
humanmouseratbacteria
biotinyl
oligo
design
captur
host
rrna
highli
express
gene
hybrid
captur
streptavidin
magnet
bead
remov
sampl
enrich
sampl
forvirusderiv
nucleic
acid
amplif
product
new
england
biolab
nebnext
rrna
deplet
kit
use
slightli
differ
approach
dna
oligo
bind
rrna
sequenc
sampl
follow
rnase
h
mediat
select
remov
hybrid
rrna
recent
new
approach
known
dash
deplet
abund
sequenc
hybrid
describ
gu
et
al
deplet
rrna
protein
complex
librari
rrna
gu
et
al
howev
major
limit
unavail
rrna
subtract
reagent
mani
vertebr
invertebr
speci
moreov
rrna
subtract
promis
look
virus
cell
tissu
sampl
usual
contain
abund
genom
dna
transcript
although
yet
avail
impact
ideal
neg
select
approach
far
reach
enabl
sensit
analysi
virom
also
compar
analysi
chang
virom
within
host
compar
virom
sampl
obtain
differ
time
point
recent
advanc
sequenc
technolog
success
exploit
viru
discoveri
virom
analysi
expand
knowledg
virus
live
around
us
howev
approach
suffici
studi
virom
sampl
host
environment
nucleic
acid
typic
present
order
magnitud
higher
viral
nucleic
acid
virus
resid
within
cell
tissu
repres
scenario
convent
viral
metagenom
fail
identifi
lowtit
virus
howev
problem
solv
increas
depth
sequenc
howev
vast
amount
sequenc
data
gener
use
metagenom
approach
pose
bioinformat
challeng
compar
analysi
virom
use
appropri
select
sequenc
approach
therefor
allow
sensit
identif
virus
also
help
reduc
bioinformat
nonvir
data
although
posit
select
approach
like
vircapseq
virocap
broad
select
probe
known
vertebr
virus
allow
comprehens
analysi
relat
virus
clinic
sampl
major
limit
techniqu
inher
bia
enrich
sampl
known
target
virus
even
basic
viru
enrich
approach
like
centrifug
filtrat
bias
therefor
giant
virus
remain
unidentifi
constitu
virom
either
fluctuat
continu
evolv
therefor
studi
use
constant
probe
set
conclus
method
appropri
select
group
virus
studi
rel
presenc
dynam
chang
popul
futur
focus
vircapseq
assay
studi
virom
fluctuat
specif
diseas
bodi
site
like
blood
respiratori
system
liver
gastrointestinatl
tract
hold
enorm
potenti
gain
new
insight
role
virom
human
health
develop
chronic
diseas
howev
believ
simpl
effici
neg
select
approach
becom
ideal
select
sequenc
approach
discoveri
new
virus
also
meaning
analysi
virom
